Jeffrey Embt

Comptroller/Controller/Auditor at JELD-WEN HOLDING, INC.

Net worth: 175 734 $ as of 2026-08-30

Producer Manufacturing

Consumer Services

Non-Energy Minerals

Profile

Mr. Jeffrey D.
Embt, CPA, is a Chief Accounting Officer at JELD-WEN Holding, Inc. Mr. Embt was previously employed as a Chief Accounting Officer by Proterra, Inc., a Chief Financial Officer by Proterra Operating Co., Inc., and a Head-Finance by BWXT Medical Ltd. He received his undergraduate degree from Coastal Carolina University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
JELD-WEN HOLDING, INC. 0.08%	2026-01-31	73,529 ( 0.08% )	175 734 $	2026-08-30

Jeffrey Embt active positions

Companies	Position	Start
JELD-WEN HOLDING, INC.	Comptroller/Controller/Auditor	2026-01-04

All active positions of Jeffrey Embt

Former positions of Jeffrey Embt

Companies	Position	End
Proterra Operating Co., Inc. Proterra Operating Co., Inc. Auto Parts: OEMProducer Manufacturing Manufactures zero-emission electric powertrain transit solutions for medium and heavy duty commercial vehicles	Director of Finance/CFO	2025-11-30
PROTERRA INC.	Comptroller/Controller/Auditor	2024-01-31
BWXT Medical Ltd. BWXT Medical Ltd. Part of BWX Technologies, Inc., BWXT Medical Ltd. is a Canadian company specializing in the development, manufacturing, and supply of advanced radiopharmaceutical products and medical isotopes for diagnostic imaging and targeted radiotherapeutic treatments. The company is based in Toronto, Canada. BWXT Medical offers a portfolio that includes isotopes such as actinium-225, germanium-68, indium-111, iodine-123, strontium-82, and technetium-99m generators, supporting clinical trials and patient treatments in more than 40 countries. The company produces radiochemicals, APIs, radiopharmaceutical unit doses, and automation solutions in a cGMP/GLP facility, and provides contract manufacturing for products like TheraSphere™ for liver cancer treatment. BWXT Medical collaborates with partners such as TRIUMF, Bayer AG, and Fusion Pharmaceuticals to advance nuclear medicine technologies and participates in organizations supporting the medical isotope sector. The CEO of the company is Jonathan W. Cirtain.	Director of Finance/CFO	-

See the detail of Jeffrey Embt's experience

Training of Jeffrey Embt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Embt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Proterra Operating Co., Inc. Proterra Operating Co., Inc. Auto Parts: OEMProducer Manufacturing Manufactures zero-emission electric powertrain transit solutions for medium and heavy duty commercial vehicles	Producer Manufacturing
Coastal Carolina University Coastal Carolina University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
JELD-WEN Holding, Inc. JELD-WEN Holding, Inc. Forest ProductsNon-Energy Minerals Manufactures doors, windows and related products	Non-Energy Minerals
BWXT Medical Ltd. BWXT Medical Ltd. Part of BWX Technologies, Inc., BWXT Medical Ltd. is a Canadian company specializing in the development, manufacturing, and supply of advanced radiopharmaceutical products and medical isotopes for diagnostic imaging and targeted radiotherapeutic treatments. The company is based in Toronto, Canada. BWXT Medical offers a portfolio that includes isotopes such as actinium-225, germanium-68, indium-111, iodine-123, strontium-82, and technetium-99m generators, supporting clinical trials and patient treatments in more than 40 countries. The company produces radiochemicals, APIs, radiopharmaceutical unit doses, and automation solutions in a cGMP/GLP facility, and provides contract manufacturing for products like TheraSphere™ for liver cancer treatment. BWXT Medical collaborates with partners such as TRIUMF, Bayer AG, and Fusion Pharmaceuticals to advance nuclear medicine technologies and participates in organizations supporting the medical isotope sector. The CEO of the company is Jonathan W. Cirtain.
Proterra, Inc. Proterra, Inc. Motor VehiclesConsumer Durables Designs and manufactures zero-emission electric transit vehicles	Consumer Durables